Navigation Links
The Leukemia & Lymphoma Society and Anjin Group Announce Multi-Year Collaborative Research Agreement
Date:4/16/2008

New Partnership under LLS's Therapy Acceleration Program to Advance

Development of a Treatment for Acute Myelogenous Leukemia

WHITE PLAINS, N.Y., April 16 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Anjin Group, Inc. today jointly announced the execution of a three-year collaborative research arrangement funded through LLS's Therapy Acceleration Program (TAP).

The arrangement provides for $2.9 million to accelerate the development of a fusion toxin protein for the treatment of acute myelogenous leukemia (AML). Continued funding will be contingent on meeting certain milestones during the course of the partnership. This partnership marks the first drug development alliance announced under TAP, an innovative program intended to advance therapies with high prospects of providing near-term benefit to patients suffering from blood cancers.

"As a company dedicated to rapid development of a drug class with significant potential for the treatment of blood cancers and a number of other severe disorders, Anjin Group is very pleased to have the sponsorship of LLS," said Bill Harrison, Chief Executive Officer of Anjin Group. "This is a significant collaboration for us, and we hope to repay LLS through the development and commercialization of therapies capable of treating a variety of blood cancers."

Louis J. DeGennaro, Ph.D., Chief Scientific Officer of LLS, added, "Our partnership with Anjin Group, the largest announced to date under LLS's Therapy Acceleration Program, is the result of a detailed, year-long selection process. By dedicating a portion of LLS's research funding to a select group of highly motivated, well positioned commercial organizations, coupled with active engagement, development services and clearly crafted milestones, we hope to assist those organizations in speeding effective therapies to our patients. As a results-oriented, patient-focused company with a genuine interest in hematological cancers,
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. September is Leukemia, Lymphoma and Myeloma Awareness Month
5. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
6. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
7. Leukemia Drug Proves Safe and Effective Over the Long Term
8. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
9. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
11. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, PainManagement-GlobalTrends ,, h...t---Global-Trends.html ,, Widespreadavailabili...andtheadventofnewdrugshaveacceleratedthepaceofgrow...imbursementstructurecontinuetoshapedemandforservic...
(Date:11/25/2009)...TAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCentryx...mtheCompany,sPROTECT-1(theProspectiveRandomizedOra...-EN(TM)(CCX282-B)inpatientswithmoderate-to-severeC...rablesafetyandtolerabilityprofile.Thestudydemonstr...aseseverityasdefinedasa70-pointdecreaseintheCrohn,...
(Date:11/24/2009)...SON,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiagno...viderofdiagnostictesting,informationandservices,an...rJaffrayHealthcareConferenceinNewYorkCity.Theprese...0a.m.EasternTime. ,, Duringtheconference,thecom...pproximate3%,operatingincometoexceed18%ofrevenues,...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Hospira Receives FDA Approval for Azithromycin for Injection 50299 1Hospira Receives FDA Approval for Azithromycin for Injection 50299 2Risk of cancer 50297 1IU School of Optometry named national vision research center 50293 1IU School of Optometry named national vision research center 50293 2IU School of Optometry named national vision research center 50293 3
...ard B. and Lynne,V. Cheney Cardiovascular Institut...r at The George Washington University host a cutti...ations around the growing forces,of genomics and p... is,intended to provide a valuable state-of-the-ar...ns of the genomics of atherosclerotic,cardiovascul...
... Candidate Vaccine Could Be Integrated Into, the ...edule in the U.S., CHICAGO, Sept. 19 GlaxoSmithK...ay that indicate that Rotarix(R), an oral,candidat...nteritis, could,be co-administered with routine in...nd four month old immunization visits, if approved...
Other Medicine Technology:Personalized Medicine - The Genomic Revolution in Cardiac Care 2Personalized Medicine - The Genomic Revolution in Cardiac Care 3New Data Show That GlaxoSmithKline's Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S. 2New Data Show That GlaxoSmithKline's Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S. 3New Data Show That GlaxoSmithKline's Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S. 4New Data Show That GlaxoSmithKline's Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S. 5
(Date:11/25/2009)...French and Spanish . , , Researchers fro...ly diagnosis of certain ocular diseases that are v...neration and keratitis, by applying an existing op...re been used for this purpose. , Scientists from...cts affected by one of these two pathologies, find...
(Date:11/25/2009)...e in French . , , Montreal, November 25, 200...e marketplace, thanks to a new partnership between...and Cognitive Sensing Inc. (CSI), a privately owne...or, which commercializes discoveries from the Univ...and CSI have announced the signature of a license ...
(Date:11/25/2009)...lead to new drugs for people, researchers say , ...phingadienes, natural lipid molecules found in soy...colon cancer, California researchers have found. ...uthors pointed out that they could help explain wh...ncer. , In the study, Dr. Julie Saba, senior sc...
(Date:11/25/2009)...dly ways to enjoy festive feasting , , W...the five-week holiday smorgasbord from Thanksgivin...he added pounds you,ll have to sweat off come Jan....tion experts, to enjoy holiday eating and make i... It,s all about devising a strategy and thinking a...
(Date:11/25/2009)...ewswire-FirstCall/-- TheProvidenceServiceCorporat...subsidiary,thenation,slargestcoordinatorofnon-emer...ofawardfromtheStateofFloridaCommissionfortheTransp...ytransportationservicestobothMiami-DadeandVolusiaC...enueovertheinitial18monthterm,issubjecttofinalized...
Breaking Medicine News(10 mins):Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:Natural Soy Component May Help Treat Colon Cancer 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3
... Medical Solutions, Inc.,(Rising), a national medi..., an electronic transaction clearinghouse company,...ectronic billing transactions,between healthcare P...ed with WorkCompEDI to implement a national,cleari...
...08 The Northern Illinois,Fire Sprinkler Advisory ...prevented a fire from spreading in a multi-unit bu...ssful activation in the Chicago area., According ...rushes had been discarded after woodwork was stain...
...n who receive microwave therapy for enlarged prost...re that could raise their risk of a heart attack o...shed recently in Mayo Clinic Proceedings. , The M...d systolic blood pressure surges of more than 30 m...
...et.com (OTC,Bulletin Board: CLAI), a leading provi...thcare industry, announced today that they have si... healthcare transactions,services. Under the terms...s., "Claimsnet is extremely pleased to add Aetna ...
...easing Concerns that Future Payment &, Coverage ...Colonoscopy Screening & Sedat...ational Coalition,for Quality Colorectal Cancer Sc...orectal cancer through educational programs,aimed ...
...ract Extension to produce $150 million of Adminis...Life of the Agreemen...poration (NYSE: PER ) and Harvard Pilgrim Health ...ntract, Harvard Pilgrim will,realize approximately...
Other Medicine News:Health News:Rising Medical Solutions and WorkCompEDI Establish Relationship to Provide Workers' Compensation eBilling Solutions 2Health News:Rising Medical Solutions and WorkCompEDI Establish Relationship to Provide Workers' Compensation eBilling Solutions 3Health News:Fire Sprinklers Prevented More Than a Dozen Major Fires This Year in Chicago Area 2Health News:Microwave treatments for enlarged prostate cause blood pressure surges 2Health News:Claimsnet Announces Agreement With Aetna for Electronic Claims and Remittance Processing 2Health News:Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care: 2Health News:Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care: 3Health News:Perot Systems and Harvard Pilgrim Extend IT and Business Process Service Relationship 2Health News:Perot Systems and Harvard Pilgrim Extend IT and Business Process Service Relationship 3Health News:Perot Systems and Harvard Pilgrim Extend IT and Business Process Service Relationship 4
Vortex Adapter for Vortex Genie 2, holds (12) 2 ml tubes
...V-500 with Vacuum Controller V-800 and water-coole...m levels from Model V-500 is a powerful PTFE me...applications. Applications Ideally suited for u...vacuum source for instruments including vacuum ove...
...V-500 with Vacuum Controller V-800 Efficiently c...mechanism turns V-500 on and off as needed to main...ful PTFE membrane vacuum pump designed to handle m...uited for use with up to two rotary evaporators ...
...m System UVS400 is a multi-tasking vacuum source a...refrigerated vapor trap and a maintenance-free, oi...e easy-to-use, wide-mouth glass condensation flask...r for easy disposal. The UVS400 provides an ideal ...
Medicine Products: